Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Ontology highlight
ABSTRACT: Novel biological subtypes and clinically important genetic aberrations (druggable lesions, prognostic factors) have been described in B-other acute lymphoblastic leukemia (ALL) during the last decade; however, due to a lack of studies on unselected cohorts, their population frequency and mutual associations still have to be established. We studied 110 consecutively diagnosed and uniformly treated childhood B-other patients using single nucleotide polymorphism arrays and whole exome/transcriptome sequencing. The frequency of DUX4-rearranged, BCR-ABL1-like, ZNF384-rearranged, ETV6-RUNX1-like, iAMP21 and MEF2D-rearranged subtypes was 27%, 15%, 5%, 5%, 4%, and 2%, respectively; 43% of cases were not classified into any of these subtypes (B-rest). We found wor
SUBMITTER: Zaliova M
PROVIDER: S-EPMC6601078 | biostudies-literature | 2019 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA